Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun to lift use of the weight loss drug, but the company will need to show more robust growth in the months ahead to bolster market ...

US lawmakers are pushing the Food and Drug Administration to control the increasing market of fake weight-loss medications.

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Baxdrostat is a highly selective, second-generation, nonimidazole aldosterone synthase inhibitor; 100 times less baxdrostat ...

LONDON (Reuters) -European companies were left wondering on Monday whether to cheer a hard-won U.S. trade deal or lament a ...

Questions, critiques and discrepancies are hanging over the framework agreement, but investors seem to view it as a win all ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Three Motley Fool contributors have picked surprisingly underrated stocks to buy right now. Here's why they chose big pharma ...

CVS acknowledged that Zepbound has been shown to help people lose more weight than Wegovy, but that Wegovy can still help ...

The United States and the European Union have reached a framework trade agreement, imposing a 15 per cent import tariff on ...

The US struck a framework trade agreement with the European Union on Sunday, imposing a 15-percent import tariff on most EU goods — half the threatened rate — and averting a bigger trade war between ...